COVID-19 antiviral protects patients whose vaccinations are incomplete: study
By
Alicia Lasek
May 09, 2023
Paxlovid offers 96% protection against hospitalization in high-risk patients who are incompletely vaccinated. It is also significantly protective in older adults who were vaccinated at least 6 months...
FDA no longer requires positive COVID-19 test to prescribe Paxlovid, Lagevrio
By
Alicia Lasek
Feb 01, 2023
The FDA on Wednesday made it easier for clinicians to prescribe these antiviral drugs in cases where transmission is evident and the patient is at high risk of severe illness.
Seven-month study supports benefits of COVID-19 antivirals in seniors
By
Alicia Lasek
Dec 15, 2022
With monoclonal antibodies no longer effective against newer strains of SARS-CoV-2, the findings support prescribing the antiviral pill Paxlovid to eligible patients, doctors say.
Stanford to test antiviral pills as long COVID treatment
By
Alicia Lasek
Nov 28, 2022
Investigators plan to test whether the antiviral drug Paxlovid will relieve symptoms of the syndrome known as long COVID, also called post-acute sequelae of COVID-19.
New treatment, prevention toolkit for clinicians addresses ‘tripledemic’
By
Alicia Lasek
Nov 15, 2022
Five medical societies have created a toolkit designed to help clinicians increase the effectiveness, accessibility and awareness of oral antiviral therapeutics and COVID-19 booster vaccines.
As respiratory diseases spike, CDC urges clinicians to offer vaccines, antivirals
By
Alicia Lasek
Nov 08, 2022
U.S. health officials have asked clinicians to help lessen the impact of an exceptional respiratory virus season on seniors and other vulnerable Americans.
Oral antivirals most effective for COVID patients with milder disease, study authors contend
By
Alicia Lasek (f3)
Jul 27, 2022
Molnupiravir and Paxlovid appear to reduce the risk of death and hospital admission without increasing adverse events in patients with mild-to-moderate COVID-19, a sweeping review of studies has found.
Paxlovid keeping hospitalizations, deaths low as COVID-19 infections rise, White House official says
By
Alicia Lasek (f3)
May 19, 2022
Clinicians are writing 20,000 prescriptions for Paxlovid each day, helping to keep severe outcomes in check, the COVID-19 Response Coordinator said Wednesday.
Antiviral pill halts SARS-CoV-2 virus activity by day 3
By
Alicia Lasek
Apr 06, 2022
New results confirm that Merck’s molnupiravir clears the virus quickly, lowering the risk of progression to severe illness in at-risk patients, researchers report.
‘They heard us’: Partner program to allow fast LTC access to federal stock of COVID-19 drugs
By
Alicia Lasek
Mar 04, 2022
The federal Long-Term Care Partner Program aims to quickly get time-sensitive COVID-19 treatments to facilities when an outbreak occurs. The first drug available via the portal will be molnupiravir, followed...